DOCSLIB.ORG

October 23, 1974, NIH Record, Vol. XXVI, No. 22

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
October 23, 1974, NIH Record, Vol. XXVI, No. 22 f\lE CO?~ ecor U . 5 . DEPARTMENT OF October 23, 1974 NATIONAL INSTITUTES OF HEALTH H EALTH . EDUCATION, AND W ELFARE Vol. XXVI, No. 22 2 NIH Grantees Share Dr. DeVita to Head NCI Dr. Gajdusek to Talk on Studies of Kuru, Nobel Prize in Medicine Cancer Treatment Div. New Guinean Disease, at Dyer Lecture By Carolyn Holstein With Another Scientist A rare insight into the mysterious workings of insidious slow viruses Two NlH grantees-Dr. George which persist in -the body months or years before fatally striking the Emil Palade and Dr. Christian de central nervous system will be offered by the National Institute of Duve-shared the Nobel Prize for Neuroioiical Diseases and Stroke Medicine or Physiology with an scientist who first demonstrated American scientist, Dr. Albert their existence-Dr. D. Carleton Claude, who heads the Institute Gajdusek. Jules Bordet in Brussels. Dr. Gajdusek, who was elected The award was announced by to membership in t he National the Royal Karolinska Institute in Academy of Sciences this year, Sweden. On Dec. 10, the scientists will deliver the 24th Annual R. E. will receive the joint Nobel Prize Dyer Lecture in the Masur Audi­ at ceremonies in Stockholm. torium on Wednesday, Nov. 6, at The three laureates were cited 8:15 p.m. for being "largely r,esponsible for Dr. DeVito, who hos received seve ral He will discuss his research to t he creation of modern cell biolo­ find the cause of kuru, the first honors including the Lasker Medico I gy" and for 'their discoveries con­ chronic degenerative disease of cerning the structural and func­ Research Award, hos frequently been man proved to be a slow virus tional organization of the cell." cited for his accomplishments in the infection. Dr. Palade i-s a grantee of botJh therapy of Hodgkin's disease. Its discovery has attracted the National Institute of General worldwide attention and stimu­ Medical Sciences and the National Dr. Vincent T. DeVita, J r., has been appointed iocting director of lated the search for additional in­ Heart and Lung Institute. fections which may possibly cause Dr. Gojdusek, who began his research Lhe Division of Cancer Treatment, on the fotol nerve disease in 19S6, NIGMS Supports Center National Cancer Institute. other subacute and chronic CNS diseases. was recently elected to membership in He heads the NIGMS-supported Dr. DeVita succeeds Dr. C. Gor­ the Notional Academy of Sciences. Molecular Pathology Center at Y,ale don Zubrod, who recently retired Stuci,ed in Mountainous Interior University. Part of that grant will to assume the post of Director of Dr. Gajdusek, chief of the year after its onset. be used for Dr. P alade's research the newly created Comprehensive Labo:ratory of Central Nervous The cause of kuru stumped the on membrane interactions in eu­ Cancer Center at the University System Studies, began studying chemists for many reasons: it did karyo-tic cells. of Miami, Florida. kuru in the mountainous interior not a ppear to be contagious; it The NH.LI grant is supporting a Dr. DeVita has been chief of the of New Guinea in 19-56. Since then, rarely occurred in men, usually study at Yale University on the NCI Medicine Branch since 1971. about 2,500 cases of kuru have only in women and children, and localization of pore systems in ca­ Previously, he served in the In­ been recorded out of a total popu­ there was an absence of all known pillary walls. Dr. Palade is the stitute's Solid Tumor Ser vice from lation of 35,000. char-acteristics of infectious di­ principal investi•gator. 1966 to 1968 as senior investiga­ Kuru, which means "shivering" sease. Dr. de Duve, a National Institute tor, and from 1968 to 1971 as head in the New Guinean Fore lan­ (See DR. GAJDUSTJJK, Pago 4) (See NOBELTSTS, Page 5) (See DR. DEVITA, Page 7) guage, is characterized by cere­ bellar ataxia and shivering-like Office for Protection tremor. It progresses in three High Blood Pressure Screening Program stages to complete motor inca­ From Research Risks For All Employees Begins in November pacity and death within about a To Coordin.ate Policy The Office for Protection from NIH will begin a high blood pressure screening program next month 15-Minute Movie Will Tel! as a health service for all employees on campus or working in buildings Research Risks, headed by Dr. in the immediate area. About High Blood Pressure Donald Chalkley, will be establish­ The screening will be carried out by the National Heart and Lung An educational film about ed on Oct . 27 in the immediate Of­ lnstitute in cooperation with the the serious problem of high fice of the Director and Deputy Di­ National High Blood Pressure diagnose hypertension (a term blood pressure will be shown rectors, NIH. Education Program and lihe En1- used to descri·be high blood pres­ in the Masur Auditorium on Th OPRR takes over the princi­ ployee Health Service using volun­ sure). Oct. 29, Oct. 30, and Nov. 1 pal functions of the Institutional teer nurses from several area hos­ Employees with aibove normal during the lunch break. Relat ions Branch, Division of Re­ pitals. blood pressure will be encouraged What Goes Up, a 15-minute search Grants, which will be Studies have consistently shown to make an appointment with the film produced by the American abolished. that about one in every seven Employee Health Service for a Heart Association, will be The former DRG branch was ele­ adults has high blood pressure. further check. Those with consis­ shown a t 11:45 a.m. and 12:15 vated to the Office of the Director Only half of these people know tently high blood pressure will be p.m. because of its expanding responsi­ they have it, and only half of referred to their own doctor or See the film and have blood bilities and the importance of co­ those who know it receive ade­ clinic for further evaluation and pressure checked during the ordinating pro.grams designed. to quate treatment. treatment. NIH High Blood Pressure protect the welfare of human sub­ A single casual reading of blood No one other than the employee Screening Program. jects of biomedical and behavioral pressure is seldom sufficient to ( See BLOOD PRI!JSE;URFJ, Page 6) (See PROTFJCTTON, Page 6) Page 2 October 23, 1974 THE NIH RECORD Students Enroll in N·IH Clinical Electives Program ecord ' Published biweekly at Bethesda, Md., by the Publications and Repor ts Branch, Office of Infor mation, for the information of employees of the National Institutes of Health, Depar tment of Health, Educa tion, and Welfare, and circulated by request to interest ed writer s and to investi­ gators in t he field of biomedical and related research. The content is reprintable without !)er mission. Pictur es are available on request. The NIH Record reserves the right to make corrections, changes or dele­ tions in submitted copy in confor mity with the pol icies of t he paper and the Depar tment of Health, Education, and Welfare. NIH Record Office ........................... Bldg. 31, Rm. 2B-03. Phone 49-62125 Editor ............................................................................. .. Fronces W. Davis Dr. Philippe V. Cardon, Jr., (seated far left), CC associate director, explains the Associote Editor ..................................................... ... Fay Levie ro program to the students who come from mony parts of the U.S. They will take port in clinical and research conferences, and receive training in one or more Staff Corresponde nts of five specialties including clinical psychophormacology, immunology, and ADA, J udy F leisher; CC, Thalia Roland; DCRT, Judith Jones; DRG, infectious diseases. Sue Meadows ; DRR, J erry Gordon; DRS, Cora M. Sult; FIC, George Presson; NCI, Carolann Hooton; NEI, Bonnie F riedman Spellane; NHLI, Seven women and twenty men selected from medical schools across Bill Sanders; NIAlD, Krin Kolsky ; NIAMDD, Pat Gorman ; NICHD, the country recently en rolled in the fall session of the NIH Clinical Kathy Kowalczyk; NIDR, Sue Hannon; NlEHS, EHzabeth Y. J a mes; Electives P rogram for Medical Students. NIGMS, Wanda Warddell; NI MH, Betty Zubovic; NINOS, Car olyn Hol­ The 9-week training course gives --------------- stein; NLM, Fran Patr ick. medical students an opportunity to ing with CC patien'ts and studying study a clinical su'bspecialty and their diseases. Administr·ative Servkes NIH Tennis Tournament Held gain firsthand experience in pa- Dr. Yecies mentioned the Na­ The finals of the NI H Tennis tient car e. The students will be tional Institute of Arthritis, Ho1ds Awards Cere·mony Club fall tournament were held working with collaborating investi- '.\1:etabolism, and Digestive Di­ The Division of Administrative Sunday afternoon, Sept. 22, at the gator,s from seven Institutes. seases' research on systemk lupus erythematosus. NIAMDD recruit- Services held its first annual Hon­ N IH tennis courts near Bldg. 41. In 1971, when the program was or Awards Ceremony in the l\'lasur Mort Stimler overcame a 5-2 first offered, Dr. Lewis Yecies, now ed SLE patients through referrals Auditorium on Oct. 7. deficit in the second set to defeat a clinical associate in the National from physicians all over the coun­ This program was the direct r e­ Adi Gazclar in straight sets for Inst itute of Allergy and Infectious try. the Men's Singles crown. Diseases, participated as a student The CC patients demonstrated sult of an EEO confe1·ence recom­ Mort and his partner, Ray Chen, while he was attending- the Uni- such a wide range of symptoms mendation that one day each year were less successful in Men's Dou­ versity of Pennsylvania Medical that it was possible to observe the be set aside to recognize those bles, however, losing in straight School.
Load more

Recommended publications
  • Nobel Prize in Medicine 1952 Was Awarded to Selman A
    History of Мedicine of the Newest period (XX-XXI centuries). EHRLICH AND ARSPHENAMINE Paul Ehrlich In 1910, with his colleague Sahachiro Hata, conducted tests on arsphenamine, once sold under the commercial name Salvarsan. Salvarsan, a synthetic preparation containing arsenic, is lethal to the microorganism responsible for syphilis. SULFONAMIDE DRUGS In 1932 the German bacteriologist Gerhard Domagk announced that the red dye Prontosil is active against streptococcal infections in mice and humans. Soon afterward French workers showed that its active antibacterial agent is sulfanilamide. In 1928 ALEXANDER FLEMING noticed the PENICILLIN inhibitory activity of a stray mold on a plate culture of staphylococcus bacteria. In 1938 HOWARD FLORY, ERNEST CHAIN received pure penicillin. In 1945 ALEXANDER FLEMING, HOWARD FLORY, ERNEST CHAIN won the Noble Prize for the discovery of penicillin and its curative effect in various infectious diseases. ANTITUBERCULOSIS DRUGS •In 1944, SELMAN WAXMAN announced the discovery of STREPTOMYCIN from cultures of a soil organism Streptomyces griseus, and stated that it was active against M. tuberculosis. •Clinincal trials confirmed this claim. •The Nobel Prize in Medicine 1952 was awarded to Selman A. Waksman •In Paris, Élie Metchnikoff had already detected the role of white blood cells in the IMMUNOLOGY immune reaction, •Jules Bordet had identified antibodies in the blood serum. •The mechanisms of antibody activity were used to devise diagnostic tests for a number of diseases. •In 1906 August von Wassermann gave his name to the blood test for syphilis, and in 1908 the tuberculin test— the skin test for tuberculosis— came into use. INSULIN •In 1921, Frederick Banting and Charles H.
    [Show full text]
  • SCIENTIFIC REPORT 2020 for the Years 2016 to 2019 Table of Contents
    SCIENTIFIC REPORT 2020 For the years 2016 to 2019 Table of Contents 3 Foreword 4 Research in Numbers 7 Strategic Vision 9 Research Pillars 10 Pillar I: Dissecting Tumour Survival Mechanisms and Tumour Microenvironment 18 Pillar II: Tracking and Targeting Minimal Residual Disease 22 Pillar III: Next Generation Molecular Imaging to Better Personalise Treatment 27 Pillar IV: Accelerating Anticancer Drug Development 33 Pillar V: Developing New Approaches to Patient Empowerment and Well-being 40 New facilities will bring new opportunities for research 41 Organisation of Research Governance Research Support Units 48 Collaborations 51 Funding Les Amis de l’Institut Bordet Research Grants 54 Visiting Medical Research Fellows (2016-2019) 55 Awards 56 Publications 2016-2019 2016-2019 (Selected Papers) Publications 2019 79 Abbreviations 2 Foreword Dominique de Valeriola General Medical Director Institut Jules Bordet is a public and academic OECI*-certified comprehensive cancer center playing an important role in cancer care, research and education, both in Belgium and internationally. Entirely dedicated to adult cancer patients since its creation in 1939, it belongs to the City of Brussels and the Université Libre de Bruxelles. Both translational and clinical research are part of the Institute’s DNA, aiming to bring research discoveries to the patient’s bedside quickly. The present 2016-2019 scientific report reflects the spirit of commitment and collaboration of the Institute’s healthcare professionals, researchers, and administrative support teams and, above all, of the patients who trust our teams and volunteer to participate in clinical trials. A concerted and well-rewarded effort has been made during these recent years to build a stronger partnership with patients in developing our clinical trials, and to establish more efficient, centralised governance and operational support for our research activities.
    [Show full text]
  • Balcomk41251.Pdf (558.9Kb)
    Copyright by Karen Suzanne Balcom 2005 The Dissertation Committee for Karen Suzanne Balcom Certifies that this is the approved version of the following dissertation: Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine Committee: E. Glynn Harmon, Supervisor Julie Hallmark Billie Grace Herring James D. Legler Brooke E. Sheldon Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine by Karen Suzanne Balcom, B.A., M.L.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin August, 2005 Dedication I dedicate this dissertation to my first teachers: my father, George Sheldon Balcom, who passed away before this task was begun, and to my mother, Marian Dyer Balcom, who passed away before it was completed. I also dedicate it to my dissertation committee members: Drs. Billie Grace Herring, Brooke Sheldon, Julie Hallmark and to my supervisor, Dr. Glynn Harmon. They were all teachers, mentors, and friends who lifted me up when I was down. Acknowledgements I would first like to thank my committee: Julie Hallmark, Billie Grace Herring, Jim Legler, M.D., Brooke E. Sheldon, and Glynn Harmon for their encouragement, patience and support during the nine years that this investigation was a work in progress. I could not have had a better committee. They are my enduring friends and I hope I prove worthy of the faith they have always showed in me. I am grateful to Dr.
    [Show full text]
  • Timeline of Immunology
    TIMELINE OF IMMUNOLOGY 1549 – The earliest account of inoculation of smallpox (variolation) occurs in Wan Quan's (1499–1582) 1718 – Smallpox inoculation in Ottoman Empire realized by West. Lady Mary Wortley Montagu, the wife of the British ambassador to Constantinople, observed the positive effects of variolation on the native population and had the technique performed on her own children. 1796 – First demonstration of smallpox vaccination (Edward Jenner) 1837 – Description of the role of microbes in putrefaction and fermentation (Theodore Schwann) 1838 – Confirmation of the role of yeast in fermentation of sugar to alcohol (Charles Cagniard-Latour) 1840 – Proposal of the germ theory of disease (Jakob Henle) 1850 – Demonstration of the contagious nature of puerperal fever (childbed fever) (Ignaz Semmelweis) 1857–1870 – Confirmation of the role of microbes in fermentation (Louis Pasteur) 1862 – Phagocytosis (Ernst Haeckel) 1867 – Aseptic practice in surgery using carbolic acid (Joseph Lister) 1876 – Demonstration that microbes can cause disease-anthrax (Robert Koch) 1877 – Mast cells (Paul Ehrlich) 1878 – Confirmation and popularization of the germ theory of disease (Louis Pasteur) 1880 – 1881 -Theory that bacterial virulence could be attenuated by culture in vitro and used as vaccines. Proposed that live attenuated microbes produced immunity by depleting host of vital trace nutrients. Used to make chicken cholera and anthrax "vaccines" (Louis Pasteur) 1883 – 1905 – Cellular theory of immunity via phagocytosis by macrophages and microphages (polymorhonuclear leukocytes) (Elie Metchnikoff) 1885 – Introduction of concept of a "therapeutic vaccination". Report of a live "attenuated" vaccine for rabies (Louis Pasteur and Pierre Paul Émile Roux). 1888 – Identification of bacterial toxins (diphtheria bacillus) (Pierre Roux and Alexandre Yersin) 1888 – Bactericidal action of blood (George Nuttall) 1890 – Demonstration of antibody activity against diphtheria and tetanus toxins.
    [Show full text]
  • Albert Claude, 1899-1983 with the Determined Intent to Fmd out Whatever There Was in It in Terms of Isolatable from Christian De Duve and George E
    ~·~-------------------------NME~W~S~AMNO~V~IE;vW~S:---------------------------- Obituary 'microsomes'. That was the beginning of a rather long side voyage that led him into the heart of the cell, not in search of a virus, but Albert Claude, 1899-1983 with the determined intent to fmd out whatever there was in it in terms of isolatable from Christian de Duve and George E. Palade particles, and to account for them in a careful quantitative manner. It was a ALBERT CLAUDE, who died in Brussels on Having failed in his first project, Claude glorious voyage during which he worked out Sunday 22 May, belonged to that small group went on to study the fate of the mouse sar­ his now classic cell-fractionation procedure. of truly exceptional individuals who, drawing coma S-37 when grafted in rats. The thesis Most of what we know today about the almost exclusively on their own resources and he wrote on his observations earned him a chemistry and activities of subcellular com­ following a vision far ahead of their time, government scholarship which he used to ponents is based on his quantitative ap­ opened single-handedly an entirely new field go to Berlin. There he frrst worked at the proach. Claude enjoyed isolating whatever of scientific investigation. Cancer Institute of the University, but was was isolatable: from microsomes to 'large He was born on 23 August 1899, in forced to leave prematurely after showing granules' (later recognized as mitochondria), Longlier, a hamlet of some 800 inhabitants that the bacterial theory of cancer genesis chromatin threads and zymogen granules.
    [Show full text]
  • Federation Member Society Nobel Laureates
    FEDERATION MEMBER SOCIETY NOBEL LAUREATES For achievements in Chemistry, Physiology/Medicine, and PHysics. Award Winners announced annually in October. Awards presented on December 10th, the anniversary of Nobel’s death. (-H represents Honorary member, -R represents Retired member) # YEAR AWARD NAME AND SOCIETY DOB DECEASED 1 1904 PM Ivan Petrovich Pavlov (APS-H) 09/14/1849 02/27/1936 for work on the physiology of digestion, through which knowledge on vital aspects of the subject has been transformed and enlarged. 2 1912 PM Alexis Carrel (APS/ASIP) 06/28/1873 01/05/1944 for work on vascular suture and the transplantation of blood vessels and organs 3 1919 PM Jules Bordet (AAI-H) 06/13/1870 04/06/1961 for discoveries relating to immunity 4 1920 PM August Krogh (APS-H) 11/15/1874 09/13/1949 (Schack August Steenberger Krogh) for discovery of the capillary motor regulating mechanism 5 1922 PM A. V. Hill (APS-H) 09/26/1886 06/03/1977 Sir Archibald Vivial Hill for discovery relating to the production of heat in the muscle 6 1922 PM Otto Meyerhof (ASBMB) 04/12/1884 10/07/1951 (Otto Fritz Meyerhof) for discovery of the fixed relationship between the consumption of oxygen and the metabolism of lactic acid in the muscle 7 1923 PM Frederick Grant Banting (ASPET) 11/14/1891 02/21/1941 for the discovery of insulin 8 1923 PM John J.R. Macleod (APS) 09/08/1876 03/16/1935 (John James Richard Macleod) for the discovery of insulin 9 1926 C Theodor Svedberg (ASBMB-H) 08/30/1884 02/26/1971 for work on disperse systems 10 1930 PM Karl Landsteiner (ASIP/AAI) 06/14/1868 06/26/1943 for discovery of human blood groups 11 1931 PM Otto Heinrich Warburg (ASBMB-H) 10/08/1883 08/03/1970 for discovery of the nature and mode of action of the respiratory enzyme 12 1932 PM Lord Edgar D.
    [Show full text]
  • Jules Bordet (1870-1961): Pioneer of Immunology
    Singapore Med J 2013; 54(9): 475-476 M edicine in S tamps doi:10.11622/smedj.2013166 Jules Bordet (1870-1961): Pioneer of immunology Jonathan Dworkin1, MD, Siang Yong Tan2, MD, JD t the time when Jules Bordet began his ground- THE TRANSFORMATION OF IMMUNOLOGY breaking experiments at the Pasteur Institute, the field Bordet began work at the Pasteur Institute in 1894, and of immunology was shrouded in pseudoscientific despite being part of Metchnikoff’s lab, he was more interested uncertainty. The lifting of this veil, through the in studying serum than white cells. The arrangement was Apersistent and patient process of experimentation, was Bordet’s an awkward one in which Bordet was compelled to put into great contribution to medicine in the 20th century. writing his research findings regarding the role of phagocytes, although in reality, his work had little to do with phagocytosis. BACKGROUND Jules Bordet was born in 1870 in Bordet possessed a reserved temperament and shunned the Soignies, a small town in Belgium. In 1874, his family moved to cult of personality that then existed around the brilliant but Brussels, and he attended a primary school in the Ecole unstable Metchnikoff. Given the contrast with his fiery Russian Moyenne, where his father taught. In secondary school, Bordet mentor, it was no surprise that Bordet evolved into a careful became interested in chemistry, and at the age of sixteen, he scientist, skeptical of broad principles derived from scant enrolled into medical school at the Free University of Brussels. data and content to draw conclusions on as narrow a basis as His early promise as a researcher earned him a scholarship the facts supported.
    [Show full text]
  • Nobel Laureates in Physiology Or Medicine
    All Nobel Laureates in Physiology or Medicine 1901 Emil A. von Behring Germany ”for his work on serum therapy, especially its application against diphtheria, by which he has opened a new road in the domain of medical science and thereby placed in the hands of the physician a victorious weapon against illness and deaths” 1902 Sir Ronald Ross Great Britain ”for his work on malaria, by which he has shown how it enters the organism and thereby has laid the foundation for successful research on this disease and methods of combating it” 1903 Niels R. Finsen Denmark ”in recognition of his contribution to the treatment of diseases, especially lupus vulgaris, with concentrated light radiation, whereby he has opened a new avenue for medical science” 1904 Ivan P. Pavlov Russia ”in recognition of his work on the physiology of digestion, through which knowledge on vital aspects of the subject has been transformed and enlarged” 1905 Robert Koch Germany ”for his investigations and discoveries in relation to tuberculosis” 1906 Camillo Golgi Italy "in recognition of their work on the structure of the nervous system" Santiago Ramon y Cajal Spain 1907 Charles L. A. Laveran France "in recognition of his work on the role played by protozoa in causing diseases" 1908 Paul Ehrlich Germany "in recognition of their work on immunity" Elie Metchniko France 1909 Emil Theodor Kocher Switzerland "for his work on the physiology, pathology and surgery of the thyroid gland" 1910 Albrecht Kossel Germany "in recognition of the contributions to our knowledge of cell chemistry made through his work on proteins, including the nucleic substances" 1911 Allvar Gullstrand Sweden "for his work on the dioptrics of the eye" 1912 Alexis Carrel France "in recognition of his work on vascular suture and the transplantation of blood vessels and organs" 1913 Charles R.
    [Show full text]
  • Elie Metchnikoff – Founder of Longevity Science – 2015
    ISSN 20790570, Advances in Gerontology, 2015, Vol. 5, No. 4, pp. 201–208. © Pleiades Publishing, Ltd., 2015. Published in Russian in Uspekhi Gerontologii, 2015, Vol. 28, No. 2, pp. 207–217. Elie Metchnikoff—The Founder of Longevity Science and a Founder of Modern Medicine: In Honor of the 170th Anniversary1 Ilia Stambler Department of Science, Technology and Society, Bar Ilan University, Ramat Gan, Israel email: [email protected] Abstract—The years 2015–2016 mark a double anniversary—the 170th anniversary of birth and the 100th anni versary of death—of one of the greatest Russian scientists, a person that may be considered a founding figure of modern immunology, aging, and longevity science—Elie Metchnikoff (May 15, 1845–July 15, 1916). At this time of rapid aging of the world population and the rapid development of technologies that may amelio rate degenerative aging processes, Metchnikoff’s pioneering contribution to the search for antiaging and healthspanextending means should be recalled and honored. Keywords: Elie Metchnikoff, medical history, aging and longevity research DOI: 10.1134/S2079057015040219 ELIE1 METCHNIKOFF—THE FOUNDER OF GERONTOLOGY The world is rapidly aging, threatening grave con sequences for the global society and economy, while the rapid development of biomedical science and technology stand as the first line of defense against the potential threat. These two everincreasing forces bring gerontology, which describes the challenges of aging while at the same time seeking means to address those challenges, to the center stage of the global sci entific, technological, and political discourse. At this time, it may be fit to honor the persons who stood at the origin of gerontological discourse, not just as a sci entific field but as a social and intellectual movement.
    [Show full text]
  • The Pluripotent History of Immunology a Review
    AVANT Volume III, Number 1/2012 www.avant.edu.pl/en 37 The pluripotent history of immunology A review Neeraja Sankaran History of Science, Technology & Medicine Underwood International College, Yonsei University, Seoul, S. Korea Abstract The historiography of immunology since 1999 is reviewed, in part as a response to claims by historians such as Thomas Söderqvist the field was still immature at the time (Söderqvist & Stillwell 1999). First addressed are the difficulties, past and present, surrounding the disciplinary definition of immunology, which is followed by a commentary on the recent scholarship devoted to the concept of the immune self. The new literature on broad immunological topics is examined and assessed, and specific charges leveled against the paucity of certain types of histories, e.g. biographical and institutional histories, are evaluated. In conclusion, there are compelling indications that the history of immunology has moved past the initial tentative stages identified in the earlier reviews to become a bustling, pluripotent discipline, much like the subject of its scrutiny, and that it continues to develop in many new and exciting directions. Keywords: Biographical history; Continuity model; Danger Model; Historiography of Immunology; History of Immunology; Institutional history; Self vs. Non-self model. Introduction Two decades ago, in the summer of 1992, the Naples Zoological Station’s summer school in the history of the life sciences, a roughly biennial event since the mid- 1970s, chose to focus on the history of immunology. Whether the meeting achieved its stated purpose of facilitating dialogue and exchange between immunologists and historians appears to have been a matter of some contention among the atten- dees (Judson & Mackay 1992; Söderqvist 1993).
    [Show full text]
  • Introduction
    Notes Introduction 1. For general literature on the history of the receptor concept see the notes below and the first chapter of this book. 2. See Bowman (1999). 3. Drews (2002). 4. ‘World Health Organization Model List of Essential Medicines’, 15th edition (2007), http://www.who.int/medicines/publications/essentialmedicines/en/; NCPA report, Bartlett (2000), http://www.ncpa.org/oped/bartlett/sep0400. html; for US figures, see Hagist and Kotlikoff (2007), www.ncpa.org/pub/ st/st286. 5. Recent examples include Schüttler (2003) and Mould (1993). 6. See the example of the scientific genetics community in the United States and Germany (Harwood 1993). For a more recent example see Robert E. Kohler’s description and analysis of the community of geneticists working on the fruit-fly drosophila (‘fly group’) (Kohler 1994; 1999). 7. Stanton (2002, esp. pp. vii–x) and Löwy (1993a, pp. v–viii). See also Pickstone (1992). 8. Hagner (2001, esp. p. 23). 9. Daniel (2001). 10. Morrell (1993, esp. p. 124). 11. Morrell (1993; 1972). 12. Moraw (1988, p. 3). 13. For details see the list of archival sources at the end of the book. 14. Concerning oral history and its problems, see Benison (1971), Perks (1990), Thompson (1991; 2000), Thompson and Perks (1993), Ward (1995), Perks and Thompson (1997) and Singer (1997). 15. Ibid. 16. Stannard (1961) and Leake (1975, p. 59). 17. Harig (1974) and Debru (1997). 18. Galen, De simplicium medicamentorum temperamentis ac facultatibus 7.12 and 11.1. Thanks to Philip van der Eijk (Newcastle) for these references. 19. Stein (1997) and Watson (1966).
    [Show full text]
  • Front Matter (PDF)
    ^^•^^^ r^^t Canœr \esearch May 1971 Volume 31 •No. 5 COVER LEGEND The Institut Jules Bordet, Centre Anticancereux de l'Université In collaboration with the Belgian National Anti-Cancer League, the Libre de Bruxelles, is a foremost cancer research and treatment Institute, since its inception, has treated over 30,000 cancer patients center of Belgium. It commemorates eponymously the eminent with the most advanced tools of radiotherapy and has maintained Belgian bacteriologist Jules Bordet (1870-1961), founder and di close follow-up surveillance on these cases. Moreover, its labora rector, until 1940, of the Institut Pasteur of Brussels. Professor tories conduct basic research on a wide range of problems, such as Bordet, who also occupied (since 1907) the Chair of Bacteriology electron microscopy of normal and neoplastic cells, cancer bio in the Faculty of Medicine at the Free University (Brussels), is chemistry, the cytogenetics of leukemia, and experimental chemo noted for his fundamental discoveries in immunology, blood coagu therapy, among others. This center has also played a prominent lation phenomena, and bacteriophage research. His contributions part in organizing international cooperation in the field of cancer rank with those of other pioneers in these fields, namely, Metch- research [see Les grands centres de cancerologie: l'Institut Jules nikoff, Ehrlich, Twort, and d'Herelle (see J. Beumer, Jules Bordet Bordet de Bruxelles (Belgique). UICC Bulletin, 5: 8, 1967]. 1870-1961. J. Gen. Microbiol., 29: 1-13, 1962). The Institute has no Director but is supervised by the College of Various honors were accorded to this gifted scientist, including the Chiefs of Service.
    [Show full text]